VaramirStart free · no cardSign in
SANA as of Nov 1 · 12:36 ET
SANANasdaqBiological Products, (No Diagnostic Substances)

Sana Biotechnology, Inc. · Brief

Next report

4 days

Nov 5 · after closeest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
2 of 8≥ implied
avg implied
±22.8%
avg realized
±9.0%
Mar 17 '25±8.9%▼−17.69%×1.99
May 8 '25±30.2%▲+0.55%×0.02
Aug 6 '25±20.0%▼−30.12%×1.51
Aug 11 '25±14.0%▲+6.51%×0.46
Q3 FY25±28.0%▲+0.99%×0.04
Q1 FY26±23.8%▼−2.80%×0.12
May 11 '26±29.1%▼−8.43%×0.29
Q2 FY26±28.3%▲+4.99%×0.18
quarterimplied−35%0+35%realized×
Q2 FY26±28.3%▲+4.99%×0.18
May '26±29.1%▼−8.43%×0.29
Q1 FY26±23.8%▼−2.80%×0.12
Q3 FY25±28.0%▲+0.99%×0.04
Aug '25±14.0%▲+6.51%×0.46
Aug '25±20.0%▼−30.12%×1.51
2 older reports
May '25±30.2%▲+0.55%×0.02
Mar '25±8.9%▼−17.69%×1.99
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 5 report · est.

Bull2 of 3

11disclosed supplier and customer ties in SEC filingsSEC filings
211managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 3

6 of 8recent reports where the move came in under the options implied rangeEarnings history
9 of 22of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

SANA report session

Suppliers 1

BEAMBeam Therapeutics, Inc. (Beam)×0.16
× = co-movement · max 500dSource: SEC filings · market data

Latest changes

30 daysAll changes
Oct 22impliedImplied move: ±30.8% into Nov 5 earnings (Oct 22 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.